3.

CINV风险预测模型特征关联性分析

Correlation analysis of characteristics of the risk prediction model for chemotherapy-induced nausea and vomiting (CINV)

Feature A	Feature B	Correlation value	Acute CINV prediction model		Delayed CINV prediction model
			Delta of ROC value after removing feature A	Delta of ROC value after removing feature B	Delta of ROC value after removing feature A	Delta of ROC value after removing feature B
Gender	History of morning sickness during a pregnancy	-0.92	0.03	-0.02	0	-0.04
Which cycle of chemotherapy	Use of non-prescribed antiemetics at home	0.81	-0.01	0.04	0.02	0.07
Nausea and vomiting occurred in the previous cycle of chemotherapy for non-first-time chemotherapy patients	Use of non-prescribed antiemetics at home	0.81	-0.03	0.04	0	0.07
NK-1 receptor antagonist used as pre-chemotherapy anti-emetics	NK-1 receptor antagonist used as post-chemotherapy anti-emetics	0.84	0.02	0.03	0	0.01